Abacavir Tablets A-Bec 300mg

Q1: What is Abacavir Tablets A-Bec 300mg IP used for?

Abacavir 300mg IP is a nucleoside reverse transcriptase inhibitor (NRTI) used as part of combination HIV-1 therapy. The 'IP' designation confirms Indian Pharmacopoeia quality standards. It is used to suppress viral replication and help restore CD4 immune function.

Q2: How does the 300mg tablet fit into HIV treatment regimens?

The 300mg tablet provides flexible dosing: 300mg twice daily as individual tablets, or combined with a 300mg lamivudine tablet for twice-daily dosing. It integrates into various combination regimens with INSTIs, NNRTIs, or boosted PIs as the third agent.

Q3: Is HLA-B*5701 testing mandatory before this Abacavir formulation?

Yes, HLA-B*5701 testing is mandatory before ANY Abacavir formulation, including A-Bec 300mg IP. A positive result means Abacavir must not be used — an alternative NRTI must be chosen.

Q4: How should A-Bec 300mg be taken?

Take with or without food at consistent times. For twice-daily dosing, spacing 12 hours apart maintains therapeutic drug levels. Never miss or delay doses — even brief interruptions can allow viral rebound and resistance development.

Q5: What is the hypersensitivity reaction risk?

2–8% of non-HLA-screened patients develop hypersensitivity syndrome (HSR) within the first 6 weeks: fever, skin rash, nausea, vomiting, fatigue, and respiratory symptoms. Stop immediately and seek medical care. Never rechallenge — fatal hypotension can result.

Q6: What are the common side effects of Abacavir 300mg?

Nausea, diarrhea, headache, fatigue, and anorexia are most common in the initial weeks. Most GI side effects improve within 1–4 weeks. Persistent or worsening symptoms should prompt medical review.

Q7: What serious side effects require emergency attention?

Hypersensitivity reaction, lactic acidosis (muscle pain, weakness, breathing difficulty — rare but serious), and hepatic steatosis/toxicity (jaundice, abdominal pain). Monitor liver function at baseline and periodically.

Q8: Does this Abacavir formulation treat hepatitis B?

No. Unlike Lamivudine and Tenofovir, Abacavir does not have significant activity against hepatitis B virus. In HIV/HBV co-infected patients, the regimen should include an HBV-active agent (Tenofovir or Lamivudine).

Q9: Can Abacavir 300mg be used during pregnancy?

Abacavir can be used in pregnancy following HLA-B*5701 testing. It is included in some HIV-in-pregnancy guidelines. The complete regimen must be planned by an HIV/OB specialist team.

Q10: What monitoring is required during treatment?

CD4 count and viral load at baseline and every 3–6 months once suppressed. Liver function at baseline and periodically. Watch for HSR symptoms for the full first 6 weeks of therapy.

Q11: How should A-Bec 300mg be stored?

Store at room temperature away from light and moisture. Keep in original packaging and out of reach of children. Do not use after the expiry date.

Q12: Do I need a prescription?

Yes. Abacavir requires specialist prescribing, mandatory HLA-B*5701 pre-testing, and regular viral load monitoring as part of a carefully designed HIV regimen.